- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05260450
Laser Treatment of Toenail Onychomycosis With a 1064 nm Nd:YAG-laser
This study aims to assess if laser treatment can cure fungal infection in toenails.
Nail clippings from eligible subjects were obtained and randomised into two groups. All nail clippings were treated once with a 1064 nm Nd:YAG-laser. Before and after treatment, nail clippings were tested for fungal infection by microscopy and by culture.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study was carried out as a randomised controlled trial (RCT) including two treatment groups subjected to two different laser treatments. A 1064 nm Nd:YAG-laser (Candela Medical, Ellipse Nordlys (Nd:YAG 1064), USA) was used for all treatments.
Potential subjects were recruited from general practitioners and skin clinics in North Jutland from August 24th, 2021, through December 2021.
All interventions and mycological tests for each subject were performed over the course of one day.
After subjects were included, toenails with a clinical suspicion of onychomycosis (OM) were tested for fungal infection by culture and microscopy. At the same time, nail clippings from said toenails were obtained and randomised into one of two treatment groups, i.e., group A and group B.
The nail clippings were then treated with a 1064 nm Nd:YAG-laser with laser settings as specified by the treatment groups. All nail clippings were treated only once.
Immediately after treatment, nail clippings were again tested for fungal infection by culture and microscopy.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Nordjylland
-
Aalborg, Nordjylland, Denmark, 9000
- Aalborg University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult patient (>18 years)
- Clinical suspicion of fungal infection in at least one toenail
- Signed informed consent
- Sufficient nail material to perform two cultures and one nail clipping
Exclusion Criteria:
- Administration of oral antifungal medication in the last 12 months or topical antifungal medication in the last month
- Diabetes mellitus with associated peripheral artery disease (PAD) or neuropathy
- Under the influence of alcohol or illegal narcotics
- Unable to understand written and spoken Danish
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group A (Long-pulsed group)
Nail clippings allocated to group A received laser treatment with a 1064 nm Nd:YAG-laser.
They received one treatment with laser settings: pulse duration 10 ms, spot size 3 mm, fluence 40-50 J/cm2, number of laser pulses 100 /cm2.
|
All interventions and mycological tests for each subject were performed over the course of one day. After subjects were included, toenails with a clinical suspicion of OM were tested for fungal infection by culture and microscopy. At the same time, nail clippings from said toenails were obtained and randomised into one of two treatment groups, i.e., group A and group B. The nail clippings were then treated with a 1064 nm Nd:YAG-laser with laser settings as specified by the treatment groups. All nail clippings were treated only once. Immediately after treatment, nail clippings were again tested for fungal infection by culture and microscopy. |
|
Active Comparator: Group B (Short-pulsed group)
Nail clippings allocated to group B received laser treatment with a 1064 nm Nd:YAG-laser.
They received one treatment with laser settings: pulse duration 0.3 ms, spot size 3 mm, fluence 40 J/cm2, number of laser pulses 100 /cm2.
|
All interventions and mycological tests for each subject were performed over the course of one day. After subjects were included, toenails with a clinical suspicion of OM were tested for fungal infection by culture and microscopy. At the same time, nail clippings from said toenails were obtained and randomised into one of two treatment groups, i.e., group A and group B. The nail clippings were then treated with a 1064 nm Nd:YAG-laser with laser settings as specified by the treatment groups. All nail clippings were treated only once. Immediately after treatment, nail clippings were again tested for fungal infection by culture and microscopy. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fungal infection status in nail clippings measured by microscopy after laser treatment.
Time Frame: Approximately 10 minutes after treatment
|
The number (rate) of included nail clippings in each group that were found negative for fungal infection measured by microscopy after therapy.
|
Approximately 10 minutes after treatment
|
|
Fungal infection status in nail clippings measured by culture after laser treatment.
Time Frame: Approximately 10 minutes after treatment
|
The number (rate) of included nail clippings in each group that were found negative for fungal infection measured by culture after therapy.
|
Approximately 10 minutes after treatment
|
|
Fungal infection status in nail clippings measured by microscopy before laser treatment.
Time Frame: Approximately 10 minutes before treatment
|
The number (rate) of included nail clippings in each group that were found negative for fungal infection measured by microscopy before therapy.
|
Approximately 10 minutes before treatment
|
|
Fungal infection status in nail clippings measured by culture before laser treatment.
Time Frame: Approximately 10 minutes before treatment
|
The number (rate) of included nail clippings in each group that were found negative for fungal infection measured by culture before therapy.
|
Approximately 10 minutes before treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fungal infection status in nail clippings measured by PCR before laser treatment.
Time Frame: Approximately 10 minutes before treatment
|
The number (rate) of included nail clippings in each group that were found negative for fungal infection measured by PCR before therapy.
|
Approximately 10 minutes before treatment
|
|
Fungal infection status in nail clippings measured by PCR after laser treatment.
Time Frame: Approximately 10 minutes after treatment
|
The number (rate) of included nail clippings in each group that were found negative for fungal infection measured by PCR after therapy.
|
Approximately 10 minutes after treatment
|
|
Nail clippings temperatures
Time Frame: Approximately 2 seconds after end of treatment.
|
Nail clippings temperature measured at the end of treatment
|
Approximately 2 seconds after end of treatment.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20210020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Onychomycosis of Toenail
-
Onyx AxiomNot yet recruiting
-
University of Alabama at BirminghamDUSA Pharmaceuticals, Inc.CompletedToenail Onychomycosis | Distal and Lateral Subungual Toenail OnychomycosisUnited States
-
Medical Life Care Planners, LLCNot yet recruitingFungal Infection | Onychomycosis of Toenail | Toenail Infection
-
Chulalongkorn UniversityKing Chulalongkorn Memorial HospitalCompleted
-
SATO Pharmaceutical Co., Ltd.Active, not recruitingOnychomycosis of ToenailUnited States
-
Oystershell NVCompletedOnychomycosis of ToenailTunisia
-
Erchonia CorporationTerminatedOnychomycosis of ToenailUnited Kingdom
-
Hallux, Inc.Active, not recruitingOnychomycosis of ToenailUnited States
-
University of Alabama at BirminghamCompleted
Clinical Trials on 1064 nm Nd:YAG-laser therapy
-
Hawler Medical UniversityCompletedRosacea, ErythematotelangiectaticIraq
-
Christopher ZacharyActive, not recruitingBasal Cell Carcinoma | Nodular Basal Cell Carcinoma | Superficial Basal Cell CarcinomaUnited States
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityCompletedAcne Scar | Acne Scars - AtrophicChina
-
University of California, IrvineCandela CorporationCompletedLocalized LipodystrophyUnited States
-
Henry Ford Health SystemCompletedHidradenitis SuppurativaUnited States
-
Stanford UniversityCompletedOnychomycosisUnited States
-
Jason K Rivers, MD, FRCPC, FAADCutera Inc.Completed
-
Universitas PadjadjaranRecruitingLaser | Skin RejuvenationIndonesia
-
Cutera Inc.WithdrawnLaser Tattoo RemovalCanada